Tiansheng Pharmaceutical Group Co Ltd (002872) - Total Liabilities
Based on the latest financial reports, Tiansheng Pharmaceutical Group Co Ltd (002872) has total liabilities worth CN¥679.17 Million CNY (≈ $99.38 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Tiansheng Pharmaceutical Group Co Ltd (002872) cash flow conversion to assess how effectively this company generates cash.
Tiansheng Pharmaceutical Group Co Ltd - Total Liabilities Trend (2012–2024)
This chart illustrates how Tiansheng Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Tiansheng Pharmaceutical Group Co Ltd's assets to evaluate the company's liquid asset resilience ratio.
Tiansheng Pharmaceutical Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Tiansheng Pharmaceutical Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AK Sigorta AS
IS:AKGRT
|
Turkey | TL22.70 Billion |
|
Te Chang Construction Co Ltd
TWO:5511
|
Taiwan | NT$7.01 Billion |
|
Humana AB (publ)
ST:HUM
|
Sweden | Skr6.14 Billion |
|
Aldel Financial II Inc. Class A Ordinary Shares
NASDAQ:ALDF
|
USA | $57.00 |
|
Bioteque
TWO:4107
|
Taiwan | NT$1.06 Billion |
|
SiS Distribution (Thailand) Public Company Limited
BK:SIS
|
Thailand | ฿7.31 Billion |
|
Chicago Atlantic Real Estate Finance Inc
NASDAQ:REFI
|
USA | $117.16 Million |
|
So-Young International Inc
NASDAQ:SY
|
USA | $852.81 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down Tiansheng Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Tiansheng Pharmaceutical Group Co Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tiansheng Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tiansheng Pharmaceutical Group Co Ltd (2012–2024)
The table below shows the annual total liabilities of Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥721.80 Million ≈ $105.62 Million |
+0.92% |
| 2023-12-31 | CN¥715.25 Million ≈ $104.66 Million |
-8.56% |
| 2022-12-31 | CN¥782.23 Million ≈ $114.47 Million |
-6.96% |
| 2021-12-31 | CN¥840.79 Million ≈ $123.03 Million |
-33.07% |
| 2020-12-31 | CN¥1.26 Billion ≈ $183.83 Million |
-12.59% |
| 2019-12-31 | CN¥1.44 Billion ≈ $210.31 Million |
-3.67% |
| 2018-12-31 | CN¥1.49 Billion ≈ $218.33 Million |
-15.09% |
| 2017-12-31 | CN¥1.76 Billion ≈ $257.13 Million |
+14.62% |
| 2016-12-31 | CN¥1.53 Billion ≈ $224.33 Million |
+23.91% |
| 2015-12-31 | CN¥1.24 Billion ≈ $181.04 Million |
+16.26% |
| 2014-12-31 | CN¥1.06 Billion ≈ $155.72 Million |
-1.58% |
| 2013-12-31 | CN¥1.08 Billion ≈ $158.21 Million |
+36.47% |
| 2012-12-31 | CN¥792.28 Million ≈ $115.94 Million |
-- |
About Tiansheng Pharmaceutical Group Co Ltd
Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, gynecological, orthopedic, cardiology, diabetes, anesthetic, and others. It also provides traditional Chinese medicines and glucose injection. The company was founded in… Read more